Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies
ConditionSmall-cell Lung Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAddario Lung Cancer Medical Institute
About this trial
This study will evaluate if a direct-to-patient, de-centralized, remote approach will improve clinical research outreach and engagement for patients with SCLC, in the context of a bio-specimen collection study. The study will also assess self-reported preferences and needs of patients with SCLC, regarding choosing and accessing novel therapies in research or standard clinical care settings and supportive gaps in this area, through an initial and 3 month follow up survey.
Eligibility criteria
Qualifiers
Men or women greater than or equal to 18 years of age at the time of consent
Ability to read, write and communicate in English
Provide voluntary consent to participate in this study, documented via a signed informed Consent Form (ICF)
Willing to provide clinical and medical information related to his/her cancer diagnoses to the study team as required
Disqualifiers
Known existence of an uncontrolled intercurrent illness including, but not limited to, psychiatric illness or social situations that would impair compliance with study requirements
Subjects who previously enrolled to this study
Trial design
Treatments tested in this trial
- Not listed
Trial groups
30 Participants
are grouped into 2 trial groupsSponsors and collaborators
Source ClinicalTrials.gov